Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alterity Therapeutics Limited

4.20
+0.810023.89%
Volume:612.47K
Turnover:2.40M
Market Cap:63.89M
PE:-2.85
High:4.29
Open:3.78
Low:3.55
Close:3.39
Loading ...
Mar 26, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 27, 2020

Report of foreign issuer

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 27, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Feb 07, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Jan 31, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Jan 17, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Jan 15, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Jan 14, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Dec 23, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Dec 11, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Nov 26, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Nov 26, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Nov 26, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Nov 21, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Nov 20, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Nov 18, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Oct 30, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Oct 25, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Sep 24, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Sep 09, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]